Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
ENNUMO joins Accord BioPharma's existing oncology supportive care portfolio: UDENYCA (pegfilgrastim-cbqv), its first long-acting pegfilgrastim biosimilar, and FILKRI (filgrastim-laha), its short-acting granulocyte colony-stimulating factor biosimilar approved in February 2026
A correlation of XDH and GSS genes' expression and poor prognosis among breast cancer patients treated with tamoxifen was seen
Results from glutathione depend on the individuals skin type, dosage, form (IV, oral, or topical), and lifestyle
While the FDA doesn't require a warning about ED, some medical research suggests a possible link
![Warrior Token [League Tokens 2014] SM248](https://cdn.shopify.com/s/files/1/0617/9821/9946/products/f5f99cec-e028-5ec7-965a-c92be9439aea.jpg?v=1658563421)
